Skip to main content
. 2023 Mar 13;14:1112816. doi: 10.3389/fimmu.2023.1112816

Figure 5.

Figure 5

Vaccine candidates (MPXV-2 and MPXV-5) docked with TLR2 and TLR4. (A) The binding mode between the MPXV-2 and TLR2 and the interacting residues of the MPXV-2 with TLR2; (B)The binding mode between the MPXV-2 and TLR4 and the interacting residues of the MPXV-2 with TLR4; (C) The binding mode between the MPXV-5 and TLR2 and the interacting residues of the MPXV-5 with TLR2; (D) The binding mode between the MPXV-5 and TLR4 and the interacting residues of the MPXV-5 with TLR4.